NDC Code(s) : 61786-534-02
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Bupropion HydrochlorideBupropion Hydrochloride TABLET, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Bupropion Hydrochloride
GENERIC: Bupropion Hydrochloride
DOSAGE: TABLET, EXTENDED RELEASE
ADMINSTRATION: ORAL
NDC: 61786-534-02
COLOR: white
SHAPE: ROUND
SCORE: No score
SIZE: 8 mm
IMPRINT: 141
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
- BUPROPION HYDROCHLORIDE 150mg in 1
INACTIVE INGREDIENT(S):
- COPOVIDONE
- METHACRYLIC ACID
- TRIETHYL CITRATE
- SODIUM BICARBONATE
- POVIDONE, UNSPECIFIED
- SODIUM LAURYL SULFATE
- TALC
- HYDROCHLORIC ACID
- HYDROXYPROPYL CELLULOSE (1200000 MW)
- SILICON DIOXIDE
- MAGNESIUM STEARATE
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POLYVINYL ALCOHOL, UNSPECIFIED
- TITANIUM DIOXIDE